Aura Biosciences Inc
AURA
Get informed when a big investor buys or sells
+ FollowMarket Cap$407.03M
Close$
$0.70
90.1% downside
Current Fair Value
90.1% downsideOvervalued by 90.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $407.03 Million |
|---|---|
| Enterprise Value | $339.22 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.76 |
| Beta | 0.39 |
| Outstanding Shares | 67,447,576 |
Return
| Return on Equity | -104.80% |
|---|---|
| Return on Assets | -81.64% |
| Return on Invested Capital | 16.53% |
Valuation & Multiples
| P/E Ratio | -3.58 |
|---|---|
| PEG | -15.87 |
| Price to Sales | - |
| Price to Book Ratio | 7.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 16.97 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | 338,300▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 84.33%▲ 8.14% |
|---|---|
| Total Invested | $340.35M▲ 24.31% |
| Investors Holding | 127▲ 11.00% |
ESG Score
No data